Deal Announcements

Biocept Floats $19 Million Initial Public Offering

Friday, February 07, 2014 5:53:00 AM PDT | VentureDeal

   San Diego, California  --  Genetic testing company Biocept (NASDAQ: BIOC) floated an initial public offering of its common shares, raising $19 million in gross proceeds.

Biocept has developed a proprietary Cell Enrichment  and Extraction technology designed to isolate and extract rare cells for accurate genetic analysis.

Company shares priced at $10 per share, within the original range of $10 - $12 per share.

Proceeds purposes are on file with company statements at the SEC.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin

PCI - Level1